Sort by
Refine Your Search
-
Listed
-
Employer
- University of Maryland, Baltimore
- Carnegie Mellon University
- Harvard University
- Nature Careers
- The Ohio State University
- The University of Arizona
- Drexel University
- New York University
- South Dakota Mines
- University of Kansas
- University of Nebraska Medical Center
- University of North Carolina at Chapel Hill
- 2 more »
- « less
-
Field
-
glass nanoparticles using flash joule heating (FJH) and understanding fundamental charge transfer mechanisms in energy storage systems. Expectations Candidates will be responsible for developing advanced
-
We are looking for motivated and talented post-docs who completed their PhD research in topics related to nanomedicine and immunotherapy research. Description of the Positions: The Steinmetz Lab
-
. The successful candidate will join a collaborative, multi-institutional research team advancing the understanding and design of enzymatic transcription reactors and lipid nanoparticle (LNP) formation systems
-
nanoparticles), in vitro and in vivo characterizations and therapeutic efficacy studies. Minimum Qualifications PhD in Organic/Medicinal Chemistry and Pharmaceutical Sciences, or relevant scientific field
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 14 days ago
Experience Requirements PhD Required Qualifications, Competencies, and Experience PhD knowledge in Gene delivery using TULEP nanoparticles Preferred Qualifications, Competencies, and Experience N/A Special
-
to nucleic acids and nanoparticles- across the blood-CSF barrier, offering promising solutions for a myriad of neurological disorders. We previously identified a promising candidate that requires further
-
Sciences | Chemistry and Biochemistry Administration A postdoctoral researcher appointment is available in the Carpenter Nanoparticle Spectroscopy Group (https://www.carpentergroup.site/) in the Department
-
on developing a microfluidic technology for loading molecules and nanoparticles into red blood cells ex vivo, with the goal of leveraging red blood cells as a biocompatible drug depot for extended release. The
-
on developing a microfluidic technology for loading molecules and nanoparticles into red blood cells ex vivo, with the goal of leveraging red blood cells as a biocompatible drug depot for extended release. The
-
cutting-edge technologies, including nanoparticle delivery systems and omics. These research projects have the potential to lead to new therapies, which will then be tested in preclinical studies